Tamar Securities’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Tamar Securities's CRDF Position: Q2 2026 in Review
Tamar Securities increased its Cardiff Oncology (CRDF) stake by 23% in Q2 2026, buying an estimated $7.07K and bringing the position to 23,795 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #97.
Tamar Securities first reported a position in CRDF in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.3K in Q4 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Tamar Securities held 23,795 shares of Cardiff Oncology worth $30.9K as of Q2 2026.
- Tamar Securities bought 4,455 Cardiff Oncology shares in Q2 2026, an estimated $7.07K.
- Cardiff Oncology made up ﹤0.01% of Tamar Securities's portfolio in Q2 2026, its #97 holding.
- Tamar Securities first reported a position in Cardiff Oncology in Q4 2025 and has held it in 3 quarters since.
- Tamar Securities's Cardiff Oncology position peaked at $32.3K in Q4 2025.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Tamar Securities's 13F filing for Q2 2026, filed 5 Aug 2026.